CN1385165A - Ribavirin aerosol inhalation solution - Google Patents
Ribavirin aerosol inhalation solution Download PDFInfo
- Publication number
- CN1385165A CN1385165A CN 02110487 CN02110487A CN1385165A CN 1385165 A CN1385165 A CN 1385165A CN 02110487 CN02110487 CN 02110487 CN 02110487 A CN02110487 A CN 02110487A CN 1385165 A CN1385165 A CN 1385165A
- Authority
- CN
- China
- Prior art keywords
- ribavirin
- aerosol inhalation
- inhalation solution
- present
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The present invention contains ribavirin, and is a ribavirn aerosol inhalation solution preparation, it can solve the problems of existent technology which is high in production cost, complex in operation and easy to produce secondary pollution.
Description
Technical field
The present invention relates to ribavirin solution technique field.
Background technology
Ribavirin claims ribavirin, virazole again, and it can hinder the synthetic of viral nucleic acid, has the broad-spectrum antiviral performance, and what be widely used clinically mostly is oral administration and drug administration by injection form greatly.At present, existing aerosol inhalation solution ribavirin on the foreign market, it is an aseptic powdery preparation.Because the ribavirin droplet can directly act on focus, forms higher drug level in the part, it is than the big several times of local drug concentration of oral administration and drug administration by injection form, and therapeutic equivalence is obvious.Prior art is with sterilized water or injection water ribavirin to be mixed with aerosol inhalation solution, again the patient is carried out atomization inspiration treatment, and still, it exists production cost height, complex operation, causes secondary pollution problem easily.
Summary of the invention
The invention provides a kind of ribavirin aerosol inhalation solution, it can solve production cost height that prior art exists, complex operation, cause secondary pollution problem easily.
Purpose of the present invention is achieved through the following technical solutions: it has ribavirin, and ribavirin is the aerosol inhalation solution preparation.
For further realizing above-mentioned purpose, take following technical scheme to finish: ribavirin and sterilized water are formulated as the aerosol inhalation solution preparation.
The beneficial effect that the present invention can produce: because of ribavirin is directly made aerosol inhalation solution, not only production cost is lower for it, and reuse sterilized water or injection water and ribavirin preparation in advance can directly be used when clinical practice, its production cost is low, simple to operate, can not cause secondary pollution.
The specific embodiment
Ribavirin aerosol inhalation solution of the present invention, it has ribavirin, and ribavirin is the aerosol inhalation solution preparation.Ribavirin and sterilized water are formulated as the aerosol inhalation solution preparation.
During making, the ribavirin aerosol made is inhaled solution insert in the sealed container and get final product after the sterilization.During use, this solution is directly injected atomizing administration device get final product.The technology that the present invention does not describe in detail partly is known technology.
Claims (2)
1, ribavirin aerosol inhalation solution, it has ribavirin, it is characterized in that: ribavirin is the aerosol inhalation solution preparation.
2, ribavirin aerosol inhalation solution according to claim 1 is characterized in that: ribavirin and sterilized water are formulated as the aerosol inhalation solution preparation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110487 CN1385165A (en) | 2002-06-05 | 2002-06-05 | Ribavirin aerosol inhalation solution |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 02110487 CN1385165A (en) | 2002-06-05 | 2002-06-05 | Ribavirin aerosol inhalation solution |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1385165A true CN1385165A (en) | 2002-12-18 |
Family
ID=4741107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 02110487 Pending CN1385165A (en) | 2002-06-05 | 2002-06-05 | Ribavirin aerosol inhalation solution |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1385165A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1304010C (en) * | 2003-04-28 | 2007-03-14 | 南昌弘益科技有限公司 | Ribavirin inhalation powder atomizing agent and its preparing process and anti-virus infection use |
| WO2011150441A1 (en) * | 2010-06-03 | 2011-12-08 | Wholesome Biopharm Pty Ltd | Medical aerosol formulation comprising ribavirin |
| CN111228244A (en) * | 2020-03-27 | 2020-06-05 | 杭州汉库医药科技有限公司 | Ribavirin inhalation preparation and application thereof in preparation of medicine for treating neocoronary pneumonia |
| CN112057438A (en) * | 2020-09-15 | 2020-12-11 | 沈阳达善医药科技有限公司 | Ribavirin solution for inhalation and preparation method and application thereof |
| CN113491676A (en) * | 2020-03-18 | 2021-10-12 | 迪斯凯威（深圳）新药发展有限公司 | Solution for ribavirin aerosol inhalation and preparation method thereof |
-
2002
- 2002-06-05 CN CN 02110487 patent/CN1385165A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1304010C (en) * | 2003-04-28 | 2007-03-14 | 南昌弘益科技有限公司 | Ribavirin inhalation powder atomizing agent and its preparing process and anti-virus infection use |
| WO2011150441A1 (en) * | 2010-06-03 | 2011-12-08 | Wholesome Biopharm Pty Ltd | Medical aerosol formulation comprising ribavirin |
| CN113491676A (en) * | 2020-03-18 | 2021-10-12 | 迪斯凯威（深圳）新药发展有限公司 | Solution for ribavirin aerosol inhalation and preparation method thereof |
| CN113491676B (en) * | 2020-03-18 | 2023-05-12 | 石家庄迪斯凯威医药科技有限公司 | Solution for atomizing inhalation of ribavirin and preparation method thereof |
| CN111228244A (en) * | 2020-03-27 | 2020-06-05 | 杭州汉库医药科技有限公司 | Ribavirin inhalation preparation and application thereof in preparation of medicine for treating neocoronary pneumonia |
| CN112057438A (en) * | 2020-09-15 | 2020-12-11 | 沈阳达善医药科技有限公司 | Ribavirin solution for inhalation and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE544445T1 (en) | PRODUCTION OF STERILE AQUEOUS SUSPENSIONS WITH MICRONIZED CRYSTALLINE ACTIVE INGREDIENTS FOR INHALATION | |
| CN203107937U (en) | Medical treatment medicine delivering cover for respiration internal medicine | |
| CN1385165A (en) | Ribavirin aerosol inhalation solution | |
| DE60318727D1 (en) | METHOD FOR PRODUCING DOSAGE INHALER FORMULATIONS | |
| CN106727321A (en) | A kind of suction ambroxol hydrochloride solution | |
| CN101090709A (en) | Nebulizer formulation | |
| CN105287846A (en) | Application of Shanhaidan Yujin injection in atomizing inhalation, spray bottle aerosol and rectal administration and method | |
| US20100305130A1 (en) | Nasal spray device and method of use thereof | |
| CN2834592Y (en) | An atomizer for treating rhinitis | |
| CN109568741A (en) | A kind of pediatric medicine drug atomization inspiration treatment instrument | |
| CN208678095U (en) | A kind of atomization medicine feed device for pediatric treatment | |
| CN204468911U (en) | The special atomized medicine introducing face shield of a kind of Respiratory Medicine | |
| CN210114722U (en) | Single-dose or small-dose nasal spray device | |
| CN203315473U (en) | Atomizer for patient suffering from tracheotomy | |
| CN202459672U (en) | Laryngeal sprayer | |
| CN201267665Y (en) | Auxiliary atomizer of breathing machine | |
| CN201361328Y (en) | Atomizing device | |
| CN110200905A (en) | A kind of ambroxol hydrochloride composition and its injection and application | |
| CN204910368U (en) | Aseptic liquid atomization ware with charge device | |
| CN108187201A (en) | A kind of atomization medicine feed device for pediatric treatment | |
| CN202505920U (en) | Respiratory tract administration apparatus | |
| CN210078497U (en) | Breathing circuit capable of carrying out atomization administration | |
| CN202892604U (en) | Anesthesia circuit ultrasonic atomizer | |
| CN219307599U (en) | Medicine micro-atomizer | |
| CN213941752U (en) | Novel paediatrics nursing atomizer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |